Mon, Jul 28, 2014, 10:07 AM EDT - U.S. Markets close in 5 hrs 53 mins


% | $
Click the to save as a favorite.

Supernus Pharmaceuticals, Inc. (SUPN) Message Board

  • blueboxvalue blueboxvalue Dec 13, 2012 2:54 PM Flag

    Decrease makes no sense

    Prior to the dilution announcement, the Company was trading at around $12 a share with 24.5 million shares outstanding - a market cap of $294 million. If you add the 6.9 million shares just sold and divide the $294 million cap by 31.4 million shares, the price should be $9.36. Understanding that the investors bought at a discount as an incentive to invest in the Company, they were able to purchase these shares at $8. There is no company news that I am aware of, nor any change in the business prospects of the Company or the industry as a whole to warrant the stock price to decrease to $7.20. This slide is extremely overdone in my opinion.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
8.79-0.15(-1.68%)10:07 AMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.